Canada in breach of ethical standards for clinical trials

CMAJ. Canadian Medical Association Journal

Volumn 186, Issue 1, 2014, Pages 11-

  Fletcher, John ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIAMORPHINE; HYDROMORPHONE; ILLICIT DRUG; METHADONE;

CANADA; CLINICAL RESEARCH; DRUG DEPENDENCE TREATMENT; DRUG EFFICACY; EDITORIAL; HEROIN DEPENDENCE; HUMAN; INFORMED CONSENT; INTERPERSONAL COMMUNICATION; MEDICAL ETHICS; PEER REVIEW; PUBLICATION; RESEARCH ETHICS; RESEARCH SUBJECT; STANDARDIZATION;

EID: 84892419963     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.131744     Document Type: Editorial

References (3)

1. Helsinki declaration. Ferney-Voltaire: World Medical Association; 2013. Available: www.wma.net/en/30publications/10policies/b3/index.html (accessed 2013 Nov. 22)
2. Oviedo-Joekes E, Brissette S, Marsh D. Diacetylmorphine versus methadone for the treatment of opioid addiction. N Engl J Med 2009;361:777-86.
3. Eggertson L. Health minister ends special access to prescription heroin. CMAJ 2013; 185:E773-4.